Tesamorelin is a growth hormone-releasing hormone (GHRH) analog, approved for reducing excess abdominal fat in HIV patients with lipodystrophy
And if you have patients who could benefit from specialist obesity medicine support, let's connect
This could explain why some users report such dramatic improvements even in chronic injuries that had been resistant to other treatments
Community protocols describe a 50 mg/day starting phase lasting 1-2 weeks, escalating to 100-150 mg/day based on tolerance
Two controlled studies concluded DSIPs sleep effect was of little clinical significance [11] and not likely to be of major therapeutic benefit. [12] That combination minutes-long half-life, non-monotonic dose-response, delayed and persistent effects, and failed replication is precisely why the field stopped
Vitamin Deficiency Solutions: Which is Right for You